Skip to main content
Journal ArticleOPEN ACCESS

Pharmaceutical efficacy of harmalol in inhibiting hepatocellular carcinoma

  • Sarkar S
  • Bhattacharjee P
  • Ghosh T
  • et al.
Future Journal of Pharmaceutical Sciences (2020) 6(1)
DOI: 10.1186/s43094-020-00045-x
N/ACitations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Diethylnitrosamine (DEN) promoted by carbon tetrachloride (CCl4) forms DNA adducts inducing hepatocellular carcinoma (HCC). Plant alkaloid, harmalol, is being used as a therapeutic agent against HCC due to its accessibility and efficacy by apoptosis and inhibiting proliferation of cancer epithelial cells.

Cite

CITATION STYLE

APA

Sarkar, S., Bhattacharjee, P., Ghosh, T., & Bhadra, K. (2020). Pharmaceutical efficacy of harmalol in inhibiting hepatocellular carcinoma. Future Journal of Pharmaceutical Sciences, 6(1). https://doi.org/10.1186/s43094-020-00045-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free